Frequency of TP53 Mutations in Relation to Arg72Pro Genotypes in Non–Small Cell Lung Cancer
Open Access
- 1 October 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 16 (10) , 2077-2081
Abstract
Mutations in the TP53 gene are important events during human lung carcinogenesis. The TP53 gene harbors several polymorphisms, and functional studies have shown that the Arg72Pro polymorphism alters both wild-type and mutant p53 protein activity. Thus, we hypothesized that certain Arg72Pro genotypes may influence the frequency and pattern of somatic mutations in TP53. We therefore examined the status of the Arg72Pro polymorphism and TP53 mutations in 260 non–small-cell lung cancer cases. Here we report a significant trend toward lower frequency of TP53 mutations with increasing number of Pro72 alleles (P = 0.02). Overall, Pro72 allele carriers had significantly lower frequency of TP53 mutations compared with Arg72 homozygotes (P = 0.02). In addition, carriage of the Pro72 variant was related to a lower frequency of mutations affecting the hotspot codon 273. Mutations at codon 273 accounted for 10.6% of the mutations in Arg72 homozygotes and 1.7% of the mutations in Pro72 allele carriers. Our results suggest that the genotype of the Arg72Pro polymorphism may modulate the frequency of TP53 mutations in non–small-cell lung cancer. (Cancer Epidemiol Biomarkers Prev 2007;16(10):2077–81)Keywords
This publication has 37 references indexed in Scilit:
- Common Genetic Variation in TP53 Is Associated with Lung Cancer Risk and Prognosis in African Americans and Somatic Mutations in Lung TumorsCancer Epidemiology, Biomarkers & Prevention, 2007
- Polymorphisms in the p53 pathwayOncogene, 2006
- Evaluation of the Combined Effect of p53 Codon 72 Polymorphism and Hotspot Mutations in Response to Anticancer DrugsClinical Cancer Research, 2005
- p53: traffic cop at the crossroads of DNA repair and recombinationNature Reviews Molecular Cell Biology, 2005
- Polymorphisms in XPD and TP53 and mutation in human lung cancerCarcinogenesis, 2004
- Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genesOncogene, 2004
- Evaluation of denaturing conditions in analysis of DNA variants applied to multi‐capillary electrophoresis instrumentsJournal of Separation Science, 2003
- The codon 72 polymorphic variants of p53 have markedly different apoptotic potentialNature Genetics, 2003
- The IARC TP53 database: New online mutation analysis and recommendations to usersHuman Mutation, 2002
- Tumour p53 mutations exhibit promoter selective dominance over wild type p53Oncogene, 2002